325 related articles for article (PubMed ID: 26984638)
1. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
3. Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.
Stanford EA; Ramirez-Cardenas A; Wang Z; Novikov O; Alamoud K; Koutrakis P; Mizgerd JP; Genco CA; Kukuruzinska M; Monti S; Bais MV; Sherr DH
Mol Cancer Res; 2016 Aug; 14(8):696-706. PubMed ID: 27130942
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
5. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
6. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
[TBL] [Abstract][Full Text] [Related]
7. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.
Narasimhan S; Stanford Zulick E; Novikov O; Parks AJ; Schlezinger JJ; Wang Z; Laroche F; Feng H; Mulas F; Monti S; Sherr DH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735912
[TBL] [Abstract][Full Text] [Related]
8. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
11. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
[TBL] [Abstract][Full Text] [Related]
12. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.
Yang X; Solomon S; Fraser LR; Trombino AF; Liu D; Sonenshein GE; Hestermann EV; Sherr DH
J Cell Biochem; 2008 May; 104(2):402-17. PubMed ID: 18059014
[TBL] [Abstract][Full Text] [Related]
13. Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.
Wu C; Yu S; Tan Q; Guo P; Liu H
Cell Cycle; 2018; 17(18):2309-2320. PubMed ID: 30311543
[TBL] [Abstract][Full Text] [Related]
14. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
Contador-Troca M; Alvarez-Barrientos A; Merino JM; Morales-Hernández A; Rodríguez MI; Rey-Barroso J; Barrasa E; Cerezo-Guisado MI; Catalina-Fernández I; Sáenz-Santamaría J; Oliver FJ; Fernandez-Salguero PM
Mol Cancer; 2015 Aug; 14():148. PubMed ID: 26242870
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells.
Wm Nor WMFSB; Chung I; Said NABM
Oncol Res; 2021 Mar; 28(6):615-629. PubMed ID: 33109304
[TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression.
Do MT; Kim HG; Tran TT; Khanal T; Choi JH; Chung YC; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2014 Oct; 280(1):138-48. PubMed ID: 25110054
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
19. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
20. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
